Today’s Wordle #917 is: SALVE
The important part is to have fun and enjoy the competition! The article talks about the Christmas Eve and winter. It also talks about the...
Life beyond Earth may form in coldest space, Ryugu samples show
– PAHs are organic compounds that can form in cold regions of space. – PAHs are found in nebulas, protoplanetary disks, the interstellar medium and...
2023 OLED TV shootout: The big three battle it out, and we all win
The author has summarized the key differences between the 3 best OLED TVs of 2023, including display tech, sound quality and UI. He also discussed...
AI reveals hidden face in painting by Renaissance master Raphael
Using AI, scientists have concluded that Raphael’s “Madonna della Rosa” features a face that was painted by someone other than Raphael. The AI was able...
Emerging Trends in Biomedical Engineering
Emerging Trends in Biomedical Engineering Introduction: Biomedical engineering is a rapidly evolving field that combines principles of engineering and medicine to improve healthcare through innovative...
OnePlus 12R specs: – 6.7-inch AMOLED display – Snapdragon 8 Gen 1 processor – 8GB or 12GB of RAM – 128GB or 256GB of storage – 50MP main camera – 8MP ultrawide camera – 2MP macro camera – 32MP front-facing camera – 4,500mAh battery – 65W fast charging
OnePlus 12R is an entry-level phone with a cheaper price and less impressive specs than OnePlus 12. It has a 6.78-inch ProXDR display, Snapdragon 8...
LG announced a new Dual-Hz OLED monitor with 4K 240Hz and FullHD 480Hz modes.
: https://www.techspot.com/news/92296-lg-unveils-range-ultragear-oled-gaming-monitors.html **LG Unveils New Range of UltraGear OLED Gaming Monitors** LG has unveiled a new range of UltraGear OLED gaming monitors, including the 32GS95UE,...
The Bank of Korea and Naver have partnered to offer a new AI-based financial service.
The Bank of Korea and Naver signed a memorandum of understanding to cooperate on Naver’s AI technology for financial and economic sectors. Naver will provide...
Nogapendekin alfa has a low likelihood of approval for gastroesophageal junction carcinomas.
Nogapendekin alfa is under clinical development by and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to GlobalData, Phase II drugs for Gastroesophageal...
Merck’s pembrolizumab has a high likelihood of approval for the treatment of natural killer cell lymphomas.
Pembrolizumab is under clinical development by and currently in Phase II for Natural Killer Cell Lymphomas. According to GlobalData, Phase II drugs for Natural Killer...